Journal of the National Cancer Institute, ‎0027-8874

Journal

21 - 28 out of 28Page size: 10

Publications

  1. 2005
  2. Published

    A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma

    Philip Johnson, 19 Oct 2005, In: Journal of the National Cancer Institute. 97, p. 1532-1538 7 p.

    Research output: Contribution to journal › Article

  3. Published

    Cancer risks and mortality in heterozygous ATM mutation carriers

    James Last, Anne Reiman, Philip Byrd, Malcolm Taylor & , 1 Jun 2005, In: Journal of the National Cancer Institute. 97, p. 813-822 10 p.

    Research output: Contribution to journal › Article

  4. Published

    Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins

    18 May 2005, In: Journal of the National Cancer Institute. 97, 10, p. 733-747 15 p.

    Research output: Contribution to journal › Article

  5. Published

    Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma

    & 2 others, & Philip Johnson, 6 Apr 2005, In: Journal of the National Cancer Institute. 97, p. 536-539 4 p.

    Research output: Contribution to journal › Article

  6. 2004
  7. Published

    Correspondence. Re: Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries

    Tom Sorahan & , 1 Jan 2004, In: Journal of the National Cancer Institute. 96, p. 966-967 2 p.

    Research output: Contribution to journal › Article

  8. 2002
  9. Published

    Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

    Philip Johnson, 6 Nov 2002, In: Journal of the National Cancer Institute. 94, p. 1614-1619 6 p.

    Research output: Contribution to journal › Article

  10. Published

    The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis

    Philip Johnson, , , & , 1 Sep 2002, In: Journal of the National Cancer Institute. 94, 18, p. 1381-1395 15 p.

    Research output: Contribution to journal › Article

  11. 2001
  12. Published

    Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression

    Farida Latif, , , , , , & , 1 May 2001, In: Journal of the National Cancer Institute. 93, 9, p. 691-699 9 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 Next